
Loading, please wait...

Loading, please wait...

Experts examined 8,047 T2D patients and found fenofibrate's benefit on sight-threatening diabetic retinopathy (STDR) was greatest in those with the lowest baseline haptoglobin (HP) levels. Fenofibrate reduced HP levels, but phenotype or change in HP did not significantly impact STDR benefit. Low baseline HP may indicate greater susceptibility to retinal oxidative injury. All HP phenotypes benefited from fenofibrate.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Experts examined 8,047 T2D patients and found fenofibrate's benefit on sight-threatening diabetic retinopathy (STDR) was greatest in those with the lowest baseline haptoglobin (HP) levels. Fenofibrate reduced HP levels, but phenotype or change in HP did not significantly impact STDR benefit. Low baseline HP may indicate greater susceptibility to retinal oxidative injury. All HP phenotypes benefited from fenofibrate.
2 months ago

As monsoon seasons elevate arboviral disease threats, Tamil Nadu has initiated an ICMR-monitored evaluation of the tetravalent dengue vaccine in Tenkasi district. Clinicians emphasize clinical monitoring, public prevention, and high-quality early pediatric care to reduce disease morbidity across endemic regions.
Today

A comparative cohort study evaluates vNOTES vs TLH hysterectomy for benign conditions, demonstrating shorter operative duration, faster return to daily activities, and equivalent female sexual function scores without increased dyspareunia.
Today

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Yesterday

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Yesterday

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today